Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) Reported Basic Consolidated EPS Of $-0.5851 For Period Ended 2015-12-31

0

The annual basic consolidated EPS for Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) for the period ended 2015-12-31 was $-0.5851. On quarterly basis, the basic consolidated EPS reading for the quarter ended 2015-12-31 was $-0.5851.

EPS from continuing operations

Coming to basic EPS from continuing operations, Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) reported $-0.5851 for the annual period ended 2015-12-31. Quarterly basic EPS from continuing operations for the three-month period ended 2015-12-31 stood at $-0.5851.

EPS contribution from parent

For the annual period ended 2015-12-31, Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) received basic EPS of $-0.5851 from its parent company. On quarterly basis, basic EPS contribution from the parent company for the period ended 2015-12-31 was $-0.5851.

Basic net EPS

For the annual period ended 2015-12-31, Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) reported basic net EPS of $-0.58. On quarterly basis, the company’s basic net EPS for the three-month period ended 2015-12-31 stood at $-0.58.

Consolidated diluted EPS

The annual consolidated diluted EPS reading for the period ended 2015-12-31 stood at $-0.5851. For the quarter ended 2015-12-31, consolidated diluted EPS was $-0.5851.

Basic diluted EPS

On annual basis, diluted EPS reading from continuing operation was $-0.5851 for the period ended 2015-12-31. Diluted EPS from continuing operations for the quarter ended 2015-12-31 was $-0.5851.

Net diluted EPS

Net diluted EPS reading for the annual period ended 2015-12-31 was $-0.58. For the quarterly period ended 2015-12-31, net diluted EPS was $-0.58.

Diluted EPS from parent

From the parent company, Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) received diluted EPS of $-0.5851 for the annual period ended 2015-12-31. On quarterly basis, diluted EPS contribution from the parent for the quarter ended 2015-12-31 was $-0.5851.

Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) posted net basic EPS reading of $-0.58 for the annual period ended 2015-12-31. For the quarter, basic net EPS of $-0.58 was for the quarter ended 2015-12-31.

Net diluted EPS for Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) for the annual period ended 2015-12-31 was $-0.58. The company also reported net diluted EPS reading of $-0.58 for the quarter ended 2015-12-31.

The annual average basic shares outstanding for the period ended 2015-12-31 is 28.229 while for the quarter ended 2015-12-31 is 28.229.

The diluted shares outstanding for the fiscal year ended is 2015-12-31 is 28.229 while for the quarter ended 2015-12-31 is 28.229.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 14 times, 1 visits today)